Qianjiang Yongan Pharmaceutical Co.,Ltd.’s Net Profit Rose 117% in First Half of 2022

Qianjiang Yongan Pharmaceutical Co.,Ltd. (潜江永安药业股份有限公司) (002365.SZ) reported a net profit of 111.5 million yuan in the first half of 2022, up 117% year-on-year.

Meanwhile, the company posted 826.9 million yuan in revenue, up 16.1% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 284.9 million yuan in total liabilities, with a liability-to-asset ratio of 12.1%.